Birkerod, Denmark

Tanja Maria Greve

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Leo-Pharma A/s. Active years: 2015.

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tanja Maria Greve: Innovator in Calcimimetic Compounds

Introduction

Tanja Maria Greve is a prominent inventor based in Birkerod, Denmark. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of calcimimetic compounds. With a total of 2 patents to her name, her work is recognized for its innovative approaches to drug formulation.

Latest Patents

Tanja's latest patents include two distinct polymorphic forms of a calcimimetic compound. The first patent describes the crystalline, polymorphic Form C of the compound {4-[(1R,3S)-3-((R)-1-Naphthalen-1-yl-ethylamino)-cyclopentyl]-phenoxy}-acetic acid. This invention details methods of preparation and characterization using techniques such as single crystal X-Ray crystallography, X-Ray Powder diffractometry, and Differential Scanning Calorimetry. The second patent focuses on the crystalline, polymorphic Form X of the same compound, outlining similar methods of preparation and characterization.

Career Highlights

Tanja Maria Greve is currently employed at Leo-Pharma A/S, where she continues to advance her research in pharmaceutical innovations. Her work has been instrumental in enhancing the understanding and application of calcimimetic compounds in medical treatments.

Collaborations

Throughout her career, Tanja has collaborated with notable colleagues, including Kim Troensegaard Nielsen and Soren Ebdrup. These partnerships have contributed to the successful development of her patented innovations.

Conclusion

Tanja Maria Greve stands out as a leading inventor in the field of calcimimetic compounds, with her patents reflecting her dedication to advancing pharmaceutical science. Her contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…